{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:16:31Z","timestamp":1788437791448,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T00:00:00Z","timestamp":1367280000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>An association between chronic obstructive pulmonary disease (COPD) and tuberculosis (TB) has been described, mainly due to smoking and corticosteroid use. Whether inhaled corticosteroid (ICS) therapy is associated with an increased risk of TB remains unclear.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We selected COPD cases by using six diagnostic scenarios and control subjects from a nationwide health insurance database, and applied time-dependent Cox regression analysis to identify the risk factors for TB.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among 1,000,000 beneficiaries, 23,594 COPD cases and 47,188 non-COPD control subjects were selected. Cox regression analysis revealed that age, male gender, diabetes mellitus, end-stage renal disease, and cirrhosis, as well as COPD (hazard ratio = 2.468 [2.205\u20132.762]) were independent risk factors for TB. Among the COPD cases, those who developed TB received more oral corticosteroids and oral \u03b2-agonists. Time-dependent Cox regression analysis revealed that age, male gender, diabetes mellitus, low income, oral corticosteroid dose, and oral \u03b2-agonist dose, but not ICS dose, were independent risk factors for TB. The identified risk factors and their hazard ratios were similar among the COPD cases selected using different scenarios.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Keeping a high suspicion and regularly monitoring for the development of pulmonary TB in COPD patients are necessary, especially for those receiving higher doses of oral corticosteroids and other COPD medications. Although ICS therapy has been shown to predispose COPD patients to pneumonia in large randomized clinical trials, it does not increase the risk of TB in real world practice.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2334-13-194","type":"journal-article","created":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T10:24:44Z","timestamp":1367317484000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Risk factors for pulmonary tuberculosis in patients with chronic obstructive airway disease in Taiwan: a nationwide cohort study"],"prefix":"10.1186","volume":"13","author":[{"given":"Chih-Hsin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chia","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Chung","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chor-Shen","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jann-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Na","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Mao","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,30]]},"reference":[{"key":"2403_CR1","volume-title":"Book Global Tuberculosis Report","author":"World Health Organization","year":"2012","unstructured":"World Health Organization: Global Tuberculosis Report. Book Global Tuberculosis Report. 2012, City: World Health Organization"},{"key":"2403_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1001\/jama.300.4.423","volume":"300","author":"DV Havlir","year":"2008","unstructured":"Havlir DV, Getahun H, Sanne I, Nunn P: Opportunities and challenges for HIV care in overlapping HIV and TB epidemics. JAMA. 2008, 300: 423-430.","journal-title":"JAMA"},{"key":"2403_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1001\/archinternmed.2008.535","volume":"169","author":"JE Oeltmann","year":"2009","unstructured":"Oeltmann JE, Kammerer JS, Pevzner ES, Moonan PK: Tuberculosis and substance abuse in the United States, 1997\u20132006. Arch Intern Med. 2009, 169: 189-197.","journal-title":"Arch Intern Med"},{"key":"2403_CR4","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1086\/503917","volume":"42","author":"M Kamboj","year":"2006","unstructured":"Kamboj M, Sepkowitz KA: The risk of tuberculosis in patients with cancer. Clin Infect Dis. 2006, 42: 1592-1595.","journal-title":"Clin Infect Dis"},{"key":"2403_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1046\/j.1525-139X.2003.03010.x","volume":"16","author":"MM Hussein","year":"2003","unstructured":"Hussein MM, Mooij JM, Roujouleh H: Tuberculosis and chronic renal disease. Semin Dial. 2003, 16: 38-44.","journal-title":"Semin Dial"},{"key":"2403_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/thx.2006.059451","volume":"62","author":"JF Ludvigsson","year":"2007","unstructured":"Ludvigsson JF, Wahlstrom J, Grunewald J, Ekbom A, Montgomery SM: Coeliac disease and risk of tuberculosis: a population based cohort study. Thorax. 2007, 62: 23-28.","journal-title":"Thorax"},{"key":"2403_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/art.21705","volume":"55","author":"SS Jick","year":"2006","unstructured":"Jick SS, Lieberman ES, Rahman MU, Choi HK: Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Rheum. 2006, 55: 19-26.","journal-title":"Arthritis Rheum"},{"key":"2403_CR8","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1164\/rccm.200703-456SO","volume":"176","author":"KF Rabe","year":"2007","unstructured":"Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007, 176: 532-555.","journal-title":"Am J Respir Crit Care Med"},{"key":"2403_CR9","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0140-6736(07)61377-4","volume":"370","author":"AS Buist","year":"2007","unstructured":"Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB: International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007, 370: 741-750.","journal-title":"Lancet"},{"key":"2403_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1378\/chest.06-0365","volume":"131","author":"L Schirnhofer","year":"2007","unstructured":"Schirnhofer L, Lamprecht B, Vollmer WM, Allison MJ, Studnicka M, Jensen RL, Buist AS: COPD prevalence in Salzburg, Austria: results from the Burden of Obstructive Lung Disease (BOLD) Study. Chest. 2007, 131: 29-36.","journal-title":"Chest"},{"key":"2403_CR11","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1183\/09031936.06.00124605","volume":"28","author":"RJ Halbert","year":"2006","unstructured":"Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM: Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006, 28: 523-532.","journal-title":"Eur Respir J"},{"key":"2403_CR12","first-page":"709","volume":"12","author":"AM Menezes","year":"2008","unstructured":"Menezes AM, Perez-Padilla R, Hallal PC, Jardim JR, Muino A, Lopez MV, Valdivia G, Pertuze J, Montes de Oca M, Talamo C: Worldwide burden of COPD in high- and low-income countries. Part II. Burden of chronic obstructive lung disease in Latin America: the PLATINO study. Int J Tuberc Lung Dis. 2008, 12: 709-712.","journal-title":"Int J Tuberc Lung Dis"},{"key":"2403_CR13","first-page":"713","volume":"12","author":"FW Ko","year":"2008","unstructured":"Ko FW, Hui DS, Lai CK: Worldwide burden of COPD in high- and low-income countries. Part III. Asia-Pacific studies. Int J Tuberc Lung Dis. 2008, 12: 713-717.","journal-title":"Int J Tuberc Lung Dis"},{"key":"2403_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1164\/rccm.200707-973OC","volume":"177","author":"JA Wedzicha","year":"2008","unstructured":"Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA: The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol\/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med. 2008, 177: 19-26.","journal-title":"Am J Respir Crit Care Med"},{"key":"2403_CR15","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1056\/NEJMoa063070","volume":"356","author":"PM Calverley","year":"2007","unstructured":"Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J: Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Eng J Med. 2007, 356: 775-789.","journal-title":"N Eng J Med"},{"key":"2403_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/MD.0b013e3181cafcd3","volume":"89","author":"CC Shu","year":"2010","unstructured":"Shu CC, Wu HD, Yu MC, Wang JT, Lee CH, Wang HC, Wang JY, Lee LN, Yu CJ, Yang PC, Taiwan Anti-Mycobacteria Investigation G: Use of high-dose inhaled corticosteroids is associated with pulmonary tuberculosis in patients with chronic obstructive pulmonary disease. Medicine. 2010, 89: 53-61.","journal-title":"Medicine"},{"key":"2403_CR17","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1164\/rccm.201007-1099OC","volume":"183","author":"P Brassard","year":"2011","unstructured":"Brassard P, Suissa S, Kezouh A, Ernst P: Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases. Am J Respir Crit Care Med. 2011, 183: 675-678.","journal-title":"Am J Respir Crit Care Med"},{"key":"2403_CR18","unstructured":"The National Health Insurance Statistics. http:\/\/www.nhi.gov.tw\/English\/webdata\/webdata.aspx?menu=11&menu_id=296&webdata_id=1942&WD_ID=296]"},{"key":"2403_CR19","doi-asserted-by":"publisher","first-page":"e37978","DOI":"10.1371\/journal.pone.0037978","volume":"7","author":"CH Lee","year":"2012","unstructured":"Lee CH, Lee MC, Lin HH, Shu CC, Wang JY, Lee LN, Chao KM: Pulmonary tuberculosis and delay in anti-tuberculous treatment are important risk factors for chronic obstructive pulmonary disease. PLoS One. 2012, 7: e37978-","journal-title":"PLoS One"},{"key":"2403_CR20","volume-title":"Taiwan Guidelines for TB Diagnosis and Treatment","year":"2011","unstructured":"Taiwan Guidelines for TB Diagnosis and Treatment. Edited by: Luh K-T. 2011, Taipei, Taiwan: Centers for Disease Control, R.O.C. (Taiwan), 4","edition":"4"},{"key":"2403_CR21","unstructured":"National Committee for Clinical Laboratory Standards (NCCLS) Antimycobacterial susceptibility testing for Mycobacterium tuberculosis: tentative standard. NCCLS document M24-T. 1995, Villanova, PA: NCCLS"},{"key":"2403_CR22","volume-title":"Guidelines for ATC classification and DDD assignment","author":"WHO Collaborating Centre for Drug Statistics Methodology","year":"2011","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology: Guidelines for ATC classification and DDD assignment. 2011, 14","edition":"14"},{"key":"2403_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1183\/09031936.00138707","volume":"31","author":"ED Bateman","year":"2008","unstructured":"Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O'Byrne P, Pedersen SE: Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008, 31: 143-178.","journal-title":"Eur Respir J"},{"key":"2403_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1046\/j.1440-1843.2003.00460.x","volume":"8","author":"COPD prevalence in 12 Asia-Pacific countries and regions","year":"2003","unstructured":"COPD prevalence in 12 Asia-Pacific countries and regions: projections based on the COPD prevalence estimation model. Respirology. 2003, 8: 192-198.","journal-title":"Respirology"},{"key":"2403_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1471-2458-10-44","volume":"10","author":"CF Wu","year":"2010","unstructured":"Wu CF, Feng NH, Chong IW, Wu KY, Lee CH, Hwang JJ, Huang CT, Lee CY, Chou ST, Christiani DC, Wu MT: Second-hand smoke and chronic bronchitis in Taiwanese women: a health-care based study. BMC Public Health. 2010, 10: 44-","journal-title":"BMC Public Health"},{"key":"2403_CR26","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S0140-6736(03)14416-9","volume":"362","author":"PM Calverley","year":"2003","unstructured":"Calverley PM, Walker P: Chronic obstructive pulmonary disease. Lancet. 2003, 362: 1053-1061.","journal-title":"Lancet"},{"key":"2403_CR27","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1164\/ajrccm.158.4.9802078","volume":"158","author":"A Di Stefano","year":"1998","unstructured":"Di Stefano A, Capelli A, Lusuardi M, Balbo P, Vecchio C, Maestrelli P, Mapp CE, Fabbri LM, Donner CF, Saetta M: Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med. 1998, 158: 1277-1285.","journal-title":"Am J Respir Crit Care Med"},{"key":"2403_CR28","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0140-6736(03)12459-2","volume":"361","author":"P Calverley","year":"2003","unstructured":"Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, Anderson J, Maden C: Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 2003, 361: 449-456.","journal-title":"Lancet"},{"key":"2403_CR29","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ophtha.2008.12.001","volume":"116","author":"JJ Wang","year":"2009","unstructured":"Wang JJ, Rochtchina E, Tan AG, Cumming RG, Leeder SR, Mitchell P: Use of inhaled and oral corticosteroids and the long-term risk of cataract. Ophthalmology. 2009, 116: 652-657.","journal-title":"Ophthalmology"},{"key":"2403_CR30","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1001\/archinte.159.9.941","volume":"159","author":"BJ Lipworth","year":"1999","unstructured":"Lipworth BJ: Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. Arch Intern Med. 1999, 159: 941-955.","journal-title":"Arch Intern Med"},{"key":"2403_CR31","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1056\/NEJMoa002304","volume":"345","author":"E Israel","year":"2001","unstructured":"Israel E, Banerjee TR, Fitzmaurice GM, Kotlov TV, LaHive K, LeBoff MS: Effects of inhaled glucocorticoids on bone density in premenopausal women. N Eng J Med. 2001, 345: 941-947.","journal-title":"N Eng J Med"},{"key":"2403_CR32","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1513\/pats.200402-018MS","volume":"1","author":"RP Schleimer","year":"2004","unstructured":"Schleimer RP: Glucocorticoids suppress inflammation but spare innate immune responses in airway epithelium. Proc Am Thorac Soc. 2004, 1: 222-230.","journal-title":"Proc Am Thorac Soc"},{"key":"2403_CR33","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1080\/02770900701743788","volume":"44","author":"PH Wang","year":"2007","unstructured":"Wang PH, Wang HC, Cheng PW, Cheng SL, Tsai CC: Hoarseness in asthmatic patients: the side effect of inhaled steroid or not?. J Asthma. 2007, 44: 823-826.","journal-title":"J Asthma"},{"key":"2403_CR34","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/S0140-6736(98)11326-0","volume":"354","author":"L Davies","year":"1999","unstructured":"Davies L, Angus RM, Calverley PM: Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet. 1999, 354: 456-460.","journal-title":"Lancet"},{"key":"2403_CR35","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1056\/NEJM199906243402502","volume":"340","author":"DE Niewoehner","year":"1999","unstructured":"Niewoehner DE, Erbland ML, Deupree RH, Collins D, Gross NJ, Light RW, Anderson P, Morgan NA: Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease, Department of Veterans Affairs Cooperative Study Group. N Eng J Med. 1999, 340: 1941-1947.","journal-title":"N Eng J Med"},{"key":"2403_CR36","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1164\/ajrccm.165.5.2109093","volume":"165","author":"F Maltais","year":"2002","unstructured":"Maltais F, Ostinelli J, Bourbeau J, Tonnel AB, Jacquemet N, Haddon J, Rouleau M, Boukhana M, Martinot JB, Duroux P: Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med. 2002, 165: 698-703.","journal-title":"Am J Respir Crit Care Med"},{"key":"2403_CR37","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1183\/09031936.00073506","volume":"29","author":"H Gunen","year":"2007","unstructured":"Gunen H, Hacievliyagil SS, Yetkin O, Gulbas G, Mutlu LC, In E: The role of nebulised budesonide in the treatment of exacerbations of COPD. Eur Respir J. 2007, 29: 660-667.","journal-title":"Eur Respir J"},{"key":"2403_CR38","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1086\/501644","volume":"20","author":"NN Bock","year":"1999","unstructured":"Bock NN, Sotir MJ, Parrott PL, Blumberg HM: Nosocomial tuberculosis exposure in an outpatient setting: evaluation of patients exposed to healthcare providers with tuberculosis. Infect Control Hosp Epidemiol. 1999, 20: 421-425.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2403_CR39","doi-asserted-by":"publisher","first-page":"e494","DOI":"10.1371\/journal.pmed.0030494","volume":"3","author":"R Joshi","year":"2006","unstructured":"Joshi R, Reingold AL, Menzies D, Pai M: Tuberculosis among health-care workers in low- and middle-income countries: a systematic review. PLoS Med. 2006, 3: e494-","journal-title":"PLoS Med"},{"key":"2403_CR40","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/cid\/cir939","volume":"54","author":"MA Baker","year":"2012","unstructured":"Baker MA, Lin HH, Chang HY, Murray MB: The risk of tuberculosis disease among persons with diabetes mellitus: a prospective cohort study. Clin Infect Dis. 2012, 54: 818-825.","journal-title":"Clin Infect Dis"},{"key":"2403_CR41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1258\/td.2010.090463","volume":"40","author":"R Baijal","year":"2010","unstructured":"Baijal R, Praveenkumar HR, Amarapurkar DN, Nagaraj K, Jain M: Prevalence of tuberculosis in patients with cirrhosis of liver in western India. Trop Doct. 2010, 40: 163-164.","journal-title":"Trop Doct"},{"key":"2403_CR42","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1164\/rccm.200904-0549OC","volume":"180","author":"HH Lin","year":"2009","unstructured":"Lin HH, Ezzati M, Chang HY, Murray M: Association between tobacco smoking and active tuberculosis in Taiwan: prospective cohort study. Am J Respir Crit Care Med. 2009, 180: 475-480.","journal-title":"Am J Respir Crit Care Med"},{"key":"2403_CR43","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S0140-6736(09)61303-9","volume":"374","author":"SS Salvi","year":"2009","unstructured":"Salvi SS, Barnes PJ: Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009, 374: 733-743.","journal-title":"Lancet"},{"key":"2403_CR44","first-page":"369","volume":"8","author":"RI Ehrlich","year":"2004","unstructured":"Ehrlich RI, White N, Norman R, Laubscher R, Steyn K, Lombard C, Bradshaw D: Predictors of chronic bronchitis in South African adults. Int J Tuberc Lung Dis. 2004, 8: 369-376.","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-194.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-13-194\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-194","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-194.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T23:46:29Z","timestamp":1630539989000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-13-194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,30]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2403"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-13-194","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,30]]},"assertion":[{"value":"30 November 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"194"}}